Literature DB >> 15704774

Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions.

Daniel H Solomon1, Charles Morris, Hailu Cheng, Danielle Cabral, Jeffrey N Katz, Joel S Finkelstein, Jerry Avorn.   

Abstract

OBJECTIVE: To assess current osteoporosis treatment guidelines, studies of osteoporosis treatment, and interventions to improve osteoporosis treatment.
METHODS: We searched the medical literature for articles published between January 1, 1992, and December 31, 2003, and assessed all relevant articles using a structured data abstraction process. Because of substantial heterogeneity in study design, no attempt was made to summarize the data using meta-analytic techniques.
RESULTS: Seventy-six articles met criteria for inclusion. Eighteen practice guidelines were studied. Most guidelines were consistent in key treatment recommendations. Among 18 studies of treatment rates in patients who had fractures, the weighted average varied from 22% for nonhormonal treatment to 19% for calcium. We found slightly higher treatment rates for patients taking oral glucocorticoids or for those older than 65 years. There were no consistent correlates of which patients received treatment. Six studies that examined treatment frequencies after bone densitometry all found that patients with lower bone mineral density were more likely to receive treatment. Most of the 8 interventions designed to improve osteoporosis treatment showed improvement in treatment rates; however, only 3 were randomized, and these showed the smallest effects.
CONCLUSIONS: Frequency of treatment of osteoporosis in at-risk populations is low. However, our assessment of the literature revealed no clear and consistent predictors of undertreatment. Few carefully controlled interventions have been reported.

Entities:  

Mesh:

Year:  2005        PMID: 15704774     DOI: 10.4065/80.2.194

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  33 in total

1.  Appraising osteoporosis care gaps.

Authors:  Thomas P Olenginski; Jana L Antohe; Elaine Sunderlin; Thomas M Harrington
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

2.  Cost and management of males with closed fractures.

Authors:  S K Brenneman; N Yurgin; Y Fan
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

3.  Hip fracture and other predictors of anti-osteoporosis drug use in Norway.

Authors:  H M Devold; A J Søgaard; A Tverdal; J A Falch; K Furu; H E Meyer
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

4.  Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule.

Authors:  D H Solomon; M A Brookhart; P Tsao; D Sundaresan; S E Andrade; K Mazor; R Yood
Journal:  Osteoporos Int       Date:  2010-09-29       Impact factor: 4.507

5.  A randomized controlled trial of mailed osteoporosis education to older adults.

Authors:  D H Solomon; J S Finkelstein; J M Polinski; M Arnold; A Licari; D Cabral; C Canning; J Avorn; J N Katz
Journal:  Osteoporos Int       Date:  2006-01-24       Impact factor: 4.507

6.  Randomized trial to improve fracture prevention in nursing home residents.

Authors:  Cathleen S Colón-Emeric; Kenneth W Lyles; Paul House; Deborah A Levine; Anna P Schenck; Jeroan Allison; Joel Gorospe; Mary Fermazin; Kristi Oliver; Jeffrey R Curtis; Norman Weissman; Aiyuan Xie; Kenneth G Saag
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

7.  Treatment for older men with fractures.

Authors:  A J Shepherd; A R Cass; L A Ray; A Tan; G S Wilkinson
Journal:  Osteoporos Int       Date:  2011-08-03       Impact factor: 4.507

8.  Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.

Authors:  T W Weiss; E S Siris; E Barrett-Connor; P D Miller; C A McHorney
Journal:  Osteoporos Int       Date:  2007-06-19       Impact factor: 4.507

9.  Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults.

Authors:  Smita Nayak; Mark S Roberts; Susan L Greenspan
Journal:  J Gen Intern Med       Date:  2009-03-10       Impact factor: 5.128

10.  Denosumab: an investigational drug for the management of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.